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ABSTRACT 
 
 
 
Akhand, Saeed S. M.S., Purdue University, August 2014. Role of a putative bacterial 
lipoprotein in Pseudomonas aeruginosa-mediated cytotoxicity towards airway cells. 
Major Professor: Gregory G. Anderson. 
 
 
 
The patients with Cystic Fibrosis (CF), an inherent genetic disorder, suffer from chronic 
bacterial infection in the lung. In CF, modification of epithelial cells leads to alteration of 
the lung environment, such as inhibition of ciliary bacterial clearance and accumulation 
of thickened mucus in the airways. Exploiting these conditions, opportunistic pathogens 
like Pseudomonas aeruginosa cause lifelong persistent infection in the CF lung by 
forming into antibiotic-resistant aggregated communities called biofilms. Airway 
infections as well as inflammation are the two major presentations of CF lung disease. P. 
aeruginosa strains isolated from CF lungs often contain mutations in the mucA gene, and 
this mutation results in higher level expression of bacterial polysaccharides and toxic 
lipoproteins. In a previous work, we have found a putative lipoprotein gene (PA4326) 
which is overexpressed in antibiotic-induced biofilm formed on cultured CF-derived 
airway cells. In the current work, we speculated that this particular putative lipoprotein 
affects cellular cytotoxicity and immune-stimulation in the epithelial cells. We found that 
mutation of this gene (∆PA4326) results in reduced airway cell killing without affecting 
other common virulence factors.  
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Moreover, we observed that this gene was able to stimulate secretion of the pro-
inflammatory cytokine IL-8 from host cells. Interestingly, we also found that ∆PA4326 
mutant strains produced less pyocyanin exotoxin compared to the wild type. Furthermore, 
our results suggest that PA4326 regulates expression of the pyocyanin biosynthesis gene 
phzM, leading to the reduced pyocyanin phenotype. Overall, these findings implicate 
PA4326 as a virulence factor in Pseudomonas aeruginosa. In the future, understating the 
molecular interplay between the epithelial cells and putative lipoproteins like PA4326 
may lead to development of novel anti-inflammatory therapies that would lessen the 
suffering of CF patients.  
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CHAPTER 1 INTRODUCTION 
 
 
 
1.1 Cystic Fibrosis 
 
Cystic fibrosis (CF) is the most common inherited genetic disorder of Caucasians. 
One in 3500 children are born with CF in United States (Rohlfs et al. 2011). At present, 
the average life expectancy of an individual with CF is 41.1 years (CFF 2012). Although 
advanced lung disease is the main reason for most CF related deaths, CF also affects 
other organs such as the pancreas, liver, and intestine (Quinton 2007; Hardin 2004; 
O’Malley 2009; Makker et al. 2009). The common signs and symptom of CF are 
shortness of breath, salty tasting skin, accumulation of thick mucus in the airways, poor 
growth, and infertility. 
This deadly genetic disease is the result of mutations in a gene that encodes for 
the cystic fibrosis transmembrane conductance regulator (CFTR). Though there are 
around 1500 mutations that lead to altered CFTR function, deletion of phenylalanine at 
the 508
th
 position of the protein (∆F508) is the most common one (Bobadilla et al. 2002). 
Primarily, CFTR functions as a chloride ion channel and is located in epithelial cells 
throughout the body. Loss of function of CFTR results in dramatic changes in the CF 
airway lining and leads to chronic bacterial infection and excessive inflammation 
(Luciani et al. 2010; Pier 2002). These complications eventually cause the loss of lung 
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function and ultimate death in patients with CF. Currently, there is no cure for CF. Lack 
of appropriate animal models of the disease makes it difficult to study the disease in vivo. 
Moreover, the available antibiotics are unable to eradicate the persistent bacterial 
infection in the CF lung due to the rapid development of drug resistance. 
 
 
1.2 Inflammation in the CF Lung 
 
Airway inflammation greatly influences the morbidity and mortality in CF 
patients. Though eosinophils, lymphocytes, and monocytes may be involved and play 
roles, excessive influx of neutrophils is the hallmark of airway inflammation in CF 
(Collins et al. 2012; Tan et al. 2011; Sorio et al. 2011; Rosenfeld et al. 2001). Neutrophil 
elastase (NE), found to be elevated in CF airways early in life, damages structural tissue 
components and is associated with lung function decline (Sagel et al. 2012). Others 
mediators such as IL–17, IL-8, IL-6, IL-1β are also detected in increased levels in CF 
(Armstrong et al. 2005; Tan et al. 2011). Over-activated NF-κB in the epithelial cells 
enhances the synthesis of these chemokines and pro-inflammatory cytokines in the CF 
airway (Kube et al. 2001; Venkatakrishnan et al. 2000; DiMango et al. 1998; Barnes & 
Karin 1997). Unfortunately, compared to normal individuals, airway secretions from CF 
patients are deficient in the immunoregulatory cytokine IL-10, which results in prolonged 
neutrophil survival and NF-κB activation (Bonfield et al. 1999; Bonfield et al. 1995; 
Moore et al. 2001; Osika et al. 1999; Lentsch et al. 1997; Schottelius et al. 1999). This 
lack of balance between pro-inflammatory and anti-inflammatory cytokines, along with 
chronic microbial infection, plays a vital role in lung inflammation in CF disease.  
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1.3 Microbial Infection in the CF Lung 
 
Along with CFTR mutation, chronic pulmonary infection is the life-threatening 
clinical feature that ultimately results in death in CF patients. Chronic bacterial infection 
and concomitant airway inflammation account for 80 to 95% of patients’ respiratory 
failure in CF (Lyczak et al. 2002). The exact mechanism of how altered CFTR leads to 
wide-spread bacterial infection is still an enigma. However, several hypotheses have been 
experimentally proposed, such as I) decreased ion transport results in decreased ciliary 
clearance of bacteria (Matsui et al. 1998), II) altered salt content in airway surfaces 
inactivates antimicrobial defensins and negatively affects the neutrophil-mediated 
bacteria killing (Smith et al. 1996), III) increased level of asialyated glycoprotein in 
airway surface acts as a receptor for P. aeruginosa (Saiman & Prince 1993), and IV) the 
intrinsic hyper inflammatory environment in the airway hinders the appropriate clearance 
of microbes (Konstan 1998). Regardless of the mechanism, it is obvious that 
microorganisms are capable of taking the full advantage of altered airway tissue and 
gradually damage the pulmonary function by causing chronic persistent infection (Hauser 
et al. 2011). 
The bacterial species that are usually found and play a role in CF pathogenesis are 
Haemophilus influenzae, Staphylococcus aureus, P. aeruginosa, Burkholderia cepacia, 
Stenotrophomonas maltophilia, Achromobacter xylosoxidans (Ciofu et al. 2013). In 
addition to bacteria, fungi (e.g. Aspergillus species) and viruses are found to infect the CF 
lung (Wat et al. 2008; Jubin et al. 2010). S. aureus is the most prevalent infecting 
microbe in early ages. However, with age, P. aeruginosa becomes more prevalent, and by 
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late twenties, P. aeruginosa is found in approximately 80% of the patients (CFF patient 
registry 2012), and it is believed to be associated with the worst outcomes in CF patients. 
As the disease progresses, the infecting organisms undergo rapid adaptation to the 
changing lung environment to evade the host immune response. Constant oxidative stress 
and antibiotic treatment induce mutation in resistance genes and even induce 
establishment of the recalcitrant biofilm lifestyle of the infecting bacteria (Hoffman et al. 
2005; Kaplan et al. 2012; Kaplan 2011).  
 
 
1.4 Pseudomonas aeruginosa 
 
The bacterium P. aeruginosa belongs to the Gammaproteobacteria class and is a 
pathogen of plants and animals, including humans (BH 1996). Generally, this Gram-
negative bacterium is classified as an aerobic organism but it has the ability to grow in 
partial or even in total oxygen-depletion conditions (Alvarez-Ortega & Harwood 2007; 
Schobert & Jahn 2010; Eschbach et al. 2004). Due to its ability to adapt to diverse 
environments, this ubiquitous organism can be found in water, soil, skin, and even in 
medical equipment, including catheters (Trautmann et al. 2005; Frimmersdorf et al. 
2010). Its large genome size (6.4 million base pairs encoding approximately 5500 genes) 
likely supports the versatility of the microorganism (Stover et al. 2000).  
While generally harmless in healthy hosts, this opportunistic organism causes 
medical complications in immunocompromised individuals such as severe pneumonia in 
CF patients, septic shock in neutropenic patients, urinary tract infection, gastrointestinal 
infection in premature infants, and skin/soft tissue infection in burn and wound patients 
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(Lyczak et al. 2000). Moreover, it has been estimated that this bacterium accounts for 
10% of hospital-acquired infections in adults as well as in children (Raymond 2006). 
P. aeruginosa produces a myriad of virulence factors such as  pili, adhesins, 
exoenzyme S, exotoxin A, phospholipase C, various proteases, siderophores, and alginate 
that enable it to cause both acute and chronic infections (Ben et al. 2011). This often-
called ‘Superbug’ is hard to eradicate because of its high level intrinsic resistance to 
diverse antibiotics (Breidenstein et al. 2011). Low permeability of the outer membrane, 
mutations affecting resistance genes, and development of adaptive resistance to 
antimicrobials have made this bacterium a formidable one to tackle (Dötsch et al. 2009; 
Alvarez-Ortega et al. 2010; Fajardo et al. 2008; Nicas & Hancock 1983).  
In addition to these numerous virulence traits, P aeruginosa can develop into 
biofilms, which provides the bacteria with another level of protection against current 
antibiotic regiments (Costerton et al. 2011). Biofilms are defined as bacterial 
communities, attached to living or abiotic surfaces, that are surrounded by a matrix of 
exopolysaccharides, DNA, and proteins (Hall-Stoodley et al. 2004). Many bacteria use a 
biofilm mode of growth as a survival strategy because it provides protection against 
antibacterial agents (Jefferson 2004). It is believed that the lack of treatment efficacy in 
CF is due to the formation of antibiotic resistance biofilm in the CF Lung (Moreau-
Marquis, Stanton, et al. 2008).  
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1.5 Pyocyanin Toxin 
 
Among a wide variety of virulence factors, pyocyanin (PYO) is one of the most 
important ones in P. aeruginosa (B Rada & Leto 2013). This heterocyclic, nitrogen 
containing blue pigment is produced from chorismic acid and secreted during stationary 
phase of the cultures (Nadal Jimenez et al. 2012). This redox-active compound can freely 
move across the biological membrane and is capable of accepting and donating electrons 
(Rada et al. 2008). PYO increases the bioavailability of iron, required for biofilm 
formation, by creating a redox potential gradient around the biofilm surfaces (Koley et al. 
2011; Moreau-Marquis, Bomberger, et al. 2008). PYO can also affect the colony 
morphology and function as a signaling molecule in quorum sensing networks in P  
aeruginosa (Dietrich et al. 2006; Dietrich et al. 2008). 
In various host organisms, PYO has been found to be essential for the full 
virulence of P.  aeruginosa. In CF, it has been reported to be involved with the lung 
function degradation, disease severity, and dominance of P. aeruginosa infection (Hunter 
et al. 2012; Wilson et al. 1988). Moreover, PYO can also cause oxidative stress and pro-
inflammatory stimulation in airway epithelial cells that are characteristic of chronic P. 
aeruginosa airway infection (Schwarzer et al. 2008; O’Malley et al. 2003). In addition to 
that, PYO has also been reported to induce mucin hyper-secretion from the airway 
epithelium, which is another prominent feature of CF lung disease (Rada et al. 2011).  
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1.6 Hypothesis 
 
One of the commonly found mutations in CF P aeruginosa isolates (in the mucA 
gene) results in constitutive activity of the AlgU sigma factor, which eventually leads to 
high level production of biofilm matrix polysaccharide (Boucher et al. 1997; Pulcrano et 
al. 2012). It is thought that prolonged exposure to inflammatory pressures induces 
mutation of mucA. It has been reported that this inflammation-stimulated biofilm 
formation of P aeruginosa due to mutation in the mucA gene correlated with over-
expression of lipoprotein genes (Firoved et al. 2004).  
P aeruginosa encodes around 175 predicted lipoproteins which accounts for ~3.2% 
of the whole genome (Remans et al. 2010) and Pseudomonas Genome Database classifies 
60% of these lipoproteins as hypothetical proteins (Winsor et al. 2009; Remans et al. 
2010). Lipoproteins have been found to play important role in the pathogenesis of many 
bacterial infections (Kovacs-Simon et al. 2011). Several antigen presenting cells can 
recognize lipoproteins via Toll-like receptors results in activation of pro-inflammatory 
cytokines (Liang et al. 2005). Studies have shown that P. aeruginosa lipoproteins, in 
particular, induce toxic effects on the airway epithelium (Firoved et al. 2004). 
Previously, in a microarray study, we observed that tobramycin treatment of P. 
aeruginosa biofilm on cystic fibrosis-derived human bronchial epithelial cells (CFBE 
cells) cultured human CF-derived airway cells (CFBE cells) led to overexpression of the 
gene PA4326 (Anderson et al. 2008). This gene is predicted to encode a lipoprotein 
(Winsor et al. 2011).  In our current study, we explored the role of this putative 
lipoprotein PA4326 in P aeruginosa-mediated cytotoxicity towards airway cells. We 
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found that mutation of PA4326 resulted in decreased killing of cultured airway cells and 
diminished secretion of IL-8 from these cells. These phenotypes correlated with 
decreased production of pyocyanin. These results suggest that disruption of PA4326 can 
dramatically affect the virulence and immmuno-stimulatory properties of P. aeruginosa.
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CHAPTER 2 METHODS AND MATERIALS 
 
 
 
2.1 Bacterial Strains and Plasmid 
 
In Table 1 and Table 2, all the bacterial strains and plasmids used in this study are 
provided. Unless otherwise noted in the text, for all the experiments P. aeruginosa strains 
were cultured in LB media supplemented with suitable antibiotics at 37⁰C overnight and 
yeast was grown in YPD (Yeast Peptone Dextrose).  
 
 
2.2 Gene Manipulations 
 
 
 
2.2.1 Deletions of Gene 
 
Utilizing an allelic replacement method as described previously by Shanks et al. 
2006, we constructed the isogenic deletion mutant strains (Shanks et al. 2006). In short, 
4326Lfor/4326Lrev and 4326Rfor/4326Rrev primers (Table 3) were used in PCR 
reaction to amplify ~1,000 bp flanking both sides of the PA4326. The amplified PCR 
product and an EcoRI cut pMQ30 plasmid vector were transformed in S. cerevisiae 
IncSc1 (Shanks et al. 2006). pMQ30 is a suicide vector for P. aeruginosa, and the PCR 
primers contained regions of homology with this plasmid such that after transformation, 
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S. cerevisiae directed recombination of the PCR fragments into the vector. The resultant 
deletion plasmid was electroporated into Escherichia coli S17-1. Conjugations were 
performed with transformant S17-1 and P. aeruginosa PA14 (Kuchma et al. 2005). LB 
plates with 5x gentamycin (1000x stock: 10 mg/ml) and 1x nalidixic acid (1000x stock: 
20 mg/ml) were used to select the successful conjugants. During conjugation, by a single-
crossover recombination step, the deletion constructs were joined at the gene locus of the 
chromosome. The strains were plated on selective LB plates (10% sucrose) to yield the 
strains with successful loss of sacB gene from the suicide vectors as a result of successful 
deletion of insert. Finally, using PCR with 4326for/4326rev primers (Table 3), the 
isogenic deletion mutant strains were validated.  
 
 
2.2.2 Gene Complementation 
 
A pair of primers 4326Comfor/4326Comrev was used to PCR amplify the gene of 
interest as well as ~500 bp upstream of the start codon; this region likely carries the 
natural promoter for PA4326. Then, an EcoR1-cut PCR fragment was ligated with EcoR1 
digested vector plasmid pMQ72 (Shanks et al. 2006) and transformed into E. coli DH5α. 
The isolated complementation plasmid pSSA004 was transformed onto ∆PA4326 using 
electroporation.  
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2.3 Growth Curve 
 
Cultures were grown overnight at 37⁰C in LB media, diluted 1:100 into fresh 
medium and sampled in triplicate in 96–well microtiter plates. Growth was measured by 
absorbance at 600nm in a spectrophotometer every 30 min for 12 hours. Samples were 
kept at 37°C throughout the assay.   
 
 
2.4 Tissue Culture 
 
Cystic fibrosis derived bronchial epithelial (CFBE) cells were used for this study 
(Cozens et al. 1994). Minimal essential medium (MEM 1x with 10% FBS, 50U/mL 
penicillin, and 50µg/mL streptomycin) was used for feeding the CFBE cells every 2-3 
days, and incubated at 37⁰C in 5% CO2.  The cells were harvested at 37⁰C in 5% CO2 
with growth media. Confluent monolayers of CFBE cells were grown in 24-well plates 
prior to the experiments (Anderson et al. 2008). Aseptic technique was maintained 
throughout the CFBE cell culture procedure. 
 
 
2.5 Cytotoxicity Assays 
 
For cytotoxicity assays, CFBE cell monolayers in 24-well plates were inoculated 
with 1.2x10
7
 CFU/mL in 0.5ml MEM/well without FBS, penicillin, streptomycin, and 
phenol red and incubated at 37°C for 1 hour. Then, the medium was removed and 
replaced with fresh medium containing 0.4% arginine, whereupon the co-culture was 
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incubated at 37°C for an additional 5 hours. Cytotoxicity was measured as a percent 
release of lactate dehydrogenase (LDH), using the CytoTox96 kit (Promega, Madison, 
WI) as directed.  
 
 
2.6 Flow Cytometry 
 
Bacteria-induced apoptosis was analyzed using a flow cytometry method. In brief, 
CFBE cells were incubated with bacteria at 37 ⁰C for 3.5 hours, and then trypsinized for 
15 minutes. Cells were collected, centrifuged in tubes, and resuspended in 200µl of 1x 
Binding Buffer (5x Binding Buffer: 50 mM HEPES, 700 mM NaCl, 12.5 mM CaCl2, pH 
7.4). After that, PE-conjugated anti-human antibody D34 monoclonal antibody, annexin 
V-FITC, and 7 aminoactinomycinD (7AAD) were added to the tubes. After incubating 
for 15 min in the dark at room temperature, the cells were analyzed in a BD 
FACSCalibur cell analyzer. This method detects the viable cells (negative for both 
annexin V and 7AAD staining), early apoptotic cells (positive for annexin V but no 
7AAD uptake), and late apoptotic/necrotic cells (binding with annexin V as well as 
positive for 7AAD uptake as a result of cytoplasmic disruption) in a sample. 
 
 
2.7 Enzyme-Linked Immunosorbent Assay (ELISA) for IL-8 
 
To measure IL-8 levels, we infected CFBE cells with P. aeruginosa for 3.5 hours 
to allow biofilm formation, as previously described (Anderson et al. 2008). The 
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supernatant was then collected and IL-8 was quantified using a Human IL-8 CytoSet™ 
ELISA kit (Invitrogen, Camarillo, CA) following the manufacturer’s protocol. 
 
 
2.8 RT-PCR Analysis 
 
For determining the level of phzM transcripts, we grew our bacterial isolates 24h 
at 37°C in LB media.  We harvested RNA, synthesized cDNA, and performed 
semiquantitative RT-PCR according to described methods (Mah et al. 2003; Kuchma et 
al. 2005), using primer pair phzMforRT/phzMrevRT (Table 3) at 56°C annealing 
temperature. We utilized fbp (fructose bisphosphatase gene) as a normalization control 
because, irrespective of growth condition, we found the same transcript level for fbp in 
several lab datasets (Anderson et al. 2008). 
 
 
2.9 Pyocyanin Assay 
 
Pyocyanin was measured with chloroform extraction methods (Essar et al. 1990). 
To enhance pyocyanin production, bacterial strains were grown overnight in King A 
medium at 37⁰C (KING et al. 1954). To determine the level of secreted pyocyanin, 500 
µl of chloroform was mixed with 1ml sample of the culture supernatant, and the lower 
organic layer was extracted. 500 µl of 200mM tris-HCl (pH 8.0) was added and the 
organic layer, rich in pyocyanin, was collected. The level of pyocyanin was determined 
by multiplying the A376 of the separated lysate with a factor of 56. To quantify the 
pyocyanin within the cells, pelleted cells from 250ml of overnight culture were washed 
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with diH2O. Afterwards, the washed cells were diluted with fresh media and mixed with 
500 µl of chloroform before proceeding with quantification as above. 
 
 
2.10 Staphylococcus aureus Killing Assays 
 
Overnight-grown bacterial cultures of wild type and mutant ∆PA4326 were 
spotted (3 µl) onto freshly swabbed LB plates with Staphylococcus aureus MZ100. After 
20-24 h of incubation at 37°C, the zones of inhibition were observed for each of the 
cultures.  
 
 
2.11 Bioassay of C4-HSL 
 
Reporter strains P. aeruginosa PAO-JP2 containing plasmid pECP61.5 was used 
for this assay. pECP61.5, which functions as a reporter of C4-HSL, contains an rhlA-lacZ 
fusion along with the rhlR gene under strong promoter tac (Ptac)(Pearson et al. 1997). In 
brief, overnight grown P. aeruginosa PAO-JP2/pECP61.5 strains were subcultured in 
5ml PTSB (5.0% peptone, 0.25% TSB & pH 7.0) media for 2 hours with added test 
supernatants. Finally, the β-galactosidase activity was measured according to previously 
described protocol (Miller 1972).  
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2.12 Biofilm Formation 
 
The crystal violet assays (O’Toole & Kolter 1998) were performed to assess the 
bacterial biofilm formation on polyvinyl chloride (PVC) plastic microtiter plates. 
Minimal M63 media supplemented with 0.4% arginine was used as biofilm media.  
 
 
2.13 Motility Assays 
 
Bacterial swimming motility was determined by pipetting 2 µl of bacterial culture 
into LB 0.3% agar plates. After incubation for 20 to 24 hours at 37°C the swimming 
zones were measured. Bacterial swarming ability was measured following a previously 
described method, using M5 medium plates with phosphate buffer, 1 M magnesium 
sulfate, 1M calcium chloride, and 20% casamino acids, with 0.4% agar (Tremblay & 
Deziel 2008). At first, 2 µl of bacterial culture were dropped onto the surface of the 
plates, and then the plates were incubated at 37°C overnight. After that, the swarming 
plates were incubated for 48h at room temperature. 
 
 
2.14 Statistical Analyses 
 
‘Mean ± standard deviation’ calculation was used to present the results. Student's 
t-tests were calculated to find out statistically significant variations among the mean 
results. A P-value < 0.05 was considered statistically significant. 
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CHAPTER 3 RESULTS 
 
 
 
3.1 PA4326 encodes a likely lipoprotein 
 
PA4326 is annotated on the Pseudomonas Genome Database (Winsor et al. 2011) 
as a putative lipoprotein. We confirmed that the protein hypothetically encoded by this 
gene contains a putative type II export signal, commonly found in lipoproteins, and this 
protein has been predicted to be lipoprotein by LipoP server (Fig. 1).  
 
 
3.2 PA4326 is involved in cytotoxicity 
 
Interestingly, we found that isogenic deletion mutation of PA4326 results in 
reduced cell killing of CFBE monolayers compared to wild type (Fig. 2). Additionally, 
we observed that the ∆PA4326 mutant is less cytotoxic toward CFBE epithelial cells than 
the wild type, as measured by release of lactate dehydrogenase (LDH) from the airway 
cells (Fig. 3). Next, we complemented the cytotoxic phenotype of the ∆PA4326 strain 
with plasmid p4326 and measured the cytotoxicity. A shown in Figure 4, wild type strain 
PA14 with empty control vector pMQ72 showed more cytotoxicity than the mutant strain 
∆PA4326 pMQ72. We also found that the complemented ∆PA4326 p4326 strain 
exhibited partially restored cytotoxic effects on the CFBE cells compared with the mutant 
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with empty vector (∆PA4326 pMQ72).To rule out the possibility of any growth defect of 
the ∆PA4326 gene, we performed bacterial growth curves in LB broth. We found that 
∆PA4326 grew similarly as the wild type strain PA14 (Fig. 5). 
 
 
3.3 PA4326 mediates cell death patterns 
 
 Because the PA4326 gene was found to be involved in cellular cytotoxicity in the 
co-culture system, we intended to investigate lipoprotein-mediated cell death patterns of 
the CFBE monolayer. To understand the cell killing (apoptosis and necrosis), we used 
flow cytometry to measure fluorescent intensity of CFBE cells stained with anti-CD34, 
annexin V, and 7 aminoactinomycin D (7-AAD) (Abrahamsen et al. 2002). This method 
detects the viable cells (negative for both annexin V and 7AAD staining), early apoptotic 
cells (positive for annexin V but no 7AAD uptake), and late apoptotic/necrotic cells 
(binding with annexin V as well as positive for 7AAD uptake as a result of cytoplasmic 
disruption) in a sample. After 3.5 hours of incubation with wild type and ∆PA4326 (Fig. 
6), the percent of early apoptotic cells was same for both the wild type (53.48%) and 
mutant (53.73%) infected cells. However, the percent of nonviable late necrotic/apoptotic 
cells was higher for wild type stimulated cells (38.75%) compared to ∆PA4326 
stimulated cells (29.26%). This data suggests that the PA4326 putative lipoprotein is 
involved in active cell killing, which is coherent with our earlier results and supports our 
hypothesis on its role in cellular tissue destruction. 
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3.4 PA4326 stimulates IL–8 production. 
 
 It has been reported that purified lipoproteins stimulate cytokine secretion from 
epithelial cells (Firoved et al. 2004). This result led us to wonder whether the putative 
lipoprotein PA4326 can also stimulate CFBE cells to express more pro-inflammatory 
cytokines. In a broader picture, we hypothesize that lipoproteins play a definite role in 
epithelial inflammation in the CF lung, and that PA4326 is an important lipoprotein in 
that process. We detected the release of the cytokine IL–8 from CFBE cell monolayers 
3.5 hours post-inoculation with different strains, using an IL-8 ELISA kit (CytoSet
TM
, 
Invitrogen). We observed 204.55 ± 39.73 pg/ml IL-8 in the supernatants CFBE cells 
inoculated with the wild type PA14 pMQ72 at this time point. In contrast, ∆PA4326 
pMQ72 mutants induced only 162.814 ± 2.4 pg/ml IL-8 (Figure 7). The CFBE cells that 
were inoculated with ∆PA4326 p4326 restored wild type-stimulated IL-8 levels (199.93 ± 
29.79 pg/ml). This observation that the PA4326 mutant stimulates a decreased amount of 
proinflammatory cytokines than wild type supports the hypothesis that this factor 
participates, in part, in the inflammatory reaction in the epithelial cells of CF patient 
lungs. 
 
 
3.5 Effects on pyocyanin production 
 
 P. aeruginosa produces a greenish blue pigment toxin called pyocyanin. This 
exotoxin of P. aerguinosa has redox active properties, can be inhibitory against 
competing microorganisms, and has been reported to cause damage in lung epithelial 
19 
 
cells during CF infection (Price-Whelan et al. 2007; Bal Rada & Leto 2013). In our 
ΔPA4326 strain, we observed that the cultures were less bluish green than the wild type 
growth culture (Fig. 8). This phenotype could be reversed by the complementation 
plasmid (p4326). This phenotypic difference made us wonder how PA4326 lipoprotein is 
affecting the production/secretion of the toxin pigment. 
 According to the Pseudomonas Genome Database, around 80% of the P. 
aeruginosa lipoproteins are outer membrane proteins playing essential structural roles 
(Winsor et al. 2011; Remans et al. 2010).  Since, as a zwitterion, pyocyanin can move 
across the cell easily, we speculated that the modification of the bacterial membrane due 
to the deletion of PA4326 might reduce the secretion of the toxin in the bacterial growth 
media. To test this hypothesis, we measured the pyocyanin quantitatively both in 
supernatant of the bacterial culture and in whole cell lysates that combine the intracellular 
compartment with the supernatant.    
 In both of the cases, we found more pyocyanin in wild type than our mutant 
∆PA4326 strain. The wild type strain secreted 58.73% more pyocyanin than ∆PA4326 in 
the culture supernatant (Fig. 9A). We also found a similar result for whole cell pyocyanin 
levels (Fig. 9B), indicating that PA4326 might affect pyocyanin synthesis rather than 
pyocyanin secretion.     
 
 
3.6 Effects on the expression of phzM 
 
 To explore further the effects of ∆PA4326 on pyocyanin synthesis, we examined 
if the deletion of PA4326 affects expression of  phzM, which is required for phenazine 
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modification in the pyocyanin biosynthesis pathway (Mavrodi et al. 2001).   PhzM is 
required to convert PCA to 5-methylphenazine-1-carboxylic acid betaine, which in turn is 
converted to pyocyanin (Mavrodi et al. 2001). qPCR showed that deletion mutation of 
PA4326 results in lower transcript level of the phzM gene (Figure 10). The level of phzM 
transcripts were 72.3% lower in ∆PA4326 than the wild type strain. These results 
indicated that lower level expression of the phzM gene may account for the reduced 
pyocyanin phenotype of ∆PA4326. 
 
 
3.7 Effects on quorum sensing molecules 
 
2-alkyl-4-quinolone (PQS) is a signaling molecule of P. aeruginosa that enhances 
the expression of rhlI and rhlR, which are essential for synthesis of the quorum sensing 
molecule C4-HSL (McKnight et al. 2000). C4-HSL induces the expression of the phzA1 
gene locus required for the conversion of chorismic acid to the pyocyanin precursor 
molecule (Whiteley et al. 1999). Thus, we tested the idea that PQS signaling was 
interrupted in ∆PA4326, resulting in low levels of C4-HSL. To answer this question, we 
determined the level of C4-HSL in the culture supernatant quantitatively using a cross-
feeding bioassay (Pearson et al. 1997). In Figure 11, we found both the wild type and the 
mutant strains were capable of producing considerable amount of C4-HSL signal 
molecule.  
To test whether PQS signaling was affected in ∆PA4326, we took advantage of 
the fact that P. aeruginosa requires PQS and related compound 4-quinolone to kill S. 
aureus and several other Gram-positive bacteria (Anon n.d.; Déziel et al. 2004). We 
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spotted 3 µl of overnight cultures of wild type, ΔPA4326, and complemented strains onto 
agar plates freshly swabbed with S. aureus, and then incubated these plates for 20–24 
hours at 37⁰C. In the co-culture plate, the zone of inhibition represents cell killing, and 
hence the active PQS molecule. We observed that the zones of inhibition were the same 
for all of the spotted strains, indicating that PQS levels were unaffected in ∆PA4326 (Fig. 
12). 
 
 
3.8 Effects on other virulence factors 
 
 To further investigate the effects of PA4326 deletion on other virulence factors, 
we measured biofilm formation. Biofilm assays were performed at various time points, 
and we found no statistical difference at any time point in biofilm development in either 
of the strains (Figure 13).  
 We also compared motility of wild type and ∆PA4326. Swarming motility was 
identical between the strains (Fig. 14A). On the other hand, swimming motility was 
slightly reduced in the ∆PA4326 strain, compared to wild type (Fig. 14B). 
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CHAPTER 4 DISCUSSION 
 
 
 
In this research study, we demonstrated that putative lipoprotein-encoding gene 
PA4326 is involved in cellular cytotoxicity and regulates bacterial pigment toxin 
production. Various studies have reported the role of lipoproteins as virulence factors in 
P. aeruginosa, particularly influencing host inflammation. Here, we reported a previously 
unstudied putative lipoprotein gene PA4326, which we found to be involved in cellular 
cytotoxicity and inflammatory reaction. Interestingly, we found that PA4326 also affected 
pyocyanin regulation via an unknown mechanism. Overall, this study supports our 
hypothesis that P. aeruginosa lipoproteins cause CF airway tissue destruction and 
remodeling as a downstream effect of immune stimulation. 
Excessive inflammation in lung tissue is one of the hallmark presentations of CF 
patients (Rowe et al. 2005; Govan & Deretic 1996). Increased IL-8 levels are common in 
the CF lung during bacterial chronic infection,  ultimately leading to neutrophil 
infiltration and elaboration of inflammatory molecules (Courtney et al. 2004). Here, we 
found that putative lipoprotein PA4326 (Fig. 1) can stimulate IL-8 secretion, which 
implied its role in overall bacterially-mediated inflammation in the CF lung (Fig. 7). 
Previously, Firoved et al. has reported that purified P. aeruginosa lipoproteins induced 
IL-8 production in primary human respiratory epithelial cells and our finding supports 
their observation (Firoved et al. 2004). Given the fact that expression of lipoproteins is 
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greatly enhanced upon contact with epithelial cells, this observation of cytokine induction 
by P. aeruginosa lipoproteins like PA4326 indicates significant clinical implications 
(Frisk et al. 2004; Chugani & Greenberg 2007). Although it has been suggested that 
TLR2 may play a role in these activities (Firoved et al. 2004), the mechanism how 
epithelial cells respond to lipoprotein PA4326 is still unclear. 
Various effector molecules of P. aeruginosa have been implicated to play a role 
in bacterially-mediated induction of apoptosis during infection (Hauser & Engel 1999; 
Shafikhani et al. 2008; Jia et al. 2006). Bacterial lipoprotein mediated cell activation and 
apoptosis have also been reported (Aliprantis 1999). Here, we made a similar observation 
with our putative lipoprotein PA4326 gene (Fig. 6). ∆PA4326 induced CFBE cells 
undergo less apoptotic/necrotic death compared to the wild type induced cell, which 
indicates the involvement of PA4326 in active bacterially-mediated cell killing.  It is 
important to note that the presented flow cytometry data are representative of a single 
experiment, requiring more experimentation to conclude anything regarding cell death 
pattern. However, this preliminary observation restated the significance of PA4326 in P. 
aeruginosa virulence. In the future, following the cell deaths (apoptosis/necrosis) over 
time would tell us a broader picture of lipoprotein-mediated cell death dynamics. 
Our results also suggest a possible regulatory function of PA4326 in bacterial 
toxin production which may be involved, in part, in cell killing. Our initial observation of 
reduced CFBE cell destruction (Fig. 2) with mutant ΔPA4326 was followed by 
quantitative measurement of the cellular cytotoxicity. We found significant reduction in 
cytotoxicity measured by LDH release with our mutant compared to wild type (Fig. 3), 
and this effect was partially reversed by the complementation vector (Fig. 4). The partial 
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complementation could be the result of lower expression of vector plasmid in the mutant 
strain due to the growth conditions and media, and does not undermine the effects of the 
PA4326 gene in virulence. The bacterial growth curve ruled out the possibility of 
defective growth of the mutant playing any role in this reduced cytotoxic phenotype (Fig. 
5). Generally, strains that have higher cytotoxicity in vitro are also found to have higher 
virulence in animal models of pneumonia (Schulert et al. 2003; Sawa et al. 1998). As a 
result, our phenotypic observation in vitro suggested a role of PA4326 and possibly other 
lipoproteins in the pathogenesis of pneumonia caused by P. aeruginosa. Moreover, 
considering our previous observation that tobramycin prevented bacterial killing of CFBE 
epithelial cells (Anderson et al. 2008), we hypothesize that antibiotic-driven selective 
pressure on bacteria may inhibit effector proteins involved in cell killing; as a result 
bacteria overexpress lipoproteins like PA4326 in an effort to compensate for reduced cell 
killing (Anderson et al. 2010; Yahr & Wolfgang 2006). More in-depth experimental 
approaches are required to elucidate the mechanism of the lipoprotein-mediated CFBE 
cell killing.  
We also made an interesting observation that our mutant strains produced less of 
the blue redox-active phenazine compound pyocyanin in growth media than wild type 
(Fig. 8). It was a very significant observation considering that pyocyanin is an important 
virulence factor for P. aeruginosa pathogenesis and has been shown to have inhibitory 
effects on cell respiration, ciliary function, and cell growth in mammalian cells (Wilson 
et al. 1987; Gee W Lau et al. 2004). Moreover, the characteristic bluish hue of CF sputum 
is the result of high level (~100 µM) pyocyanin accumulation  (Wilson et al. 1988), and 
pyocyanin has also been reported to induce oxidative stress and apoptosis in neutrophils 
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(Usher et al. 2002; Muller 2002). We believe that the reduced CFBE cell destructions 
with ∆PA4326, as well as cytokine and apopotosis effects were the result, in part, of this 
reduced pyocyanin phenotype. 
The question how PA4326 is affecting exotoxin pyocyanin is still not clear. 
Initially, we thought that PA4326 might affect the membrane transportation of pyocyanin, 
as most P. aeruginosa lipoproteins (80%) are outer membrane proteins and play 
important structural role (Remans et al. 2010). However, we found deficiency in 
production of pyocyanin both in culture supernatant and in whole cell lysate indicating 
that PA4326 might be involved in pyocyanin synthesis rather than in secretion (Fig. 
9).This observation was not surprising as plenty of other P. aeruginosa toxic lipoproteins 
have been implicated in regulatory roles (Remans et al. 2010; Gee W. Lau et al. 2004). 
Moreover, this observation also demands investigation of the cellular localization of the 
putative lipoprotein PA4326, to determine whether it, in fact, resides in the outer 
membrane.  
To further elucidate the relationships between PA4326 and pyocyanin, we also 
showed that deletion of PA4326 resulted in low level expression of phzM transcripts (Fig. 
10). phzM, encoding a SAM-dependent methyltransferase, is a crucial gene which 
converts the phenazine intermediate to 5-methylphenazine-1-carboxylic acid betaine 
which in turn is converted to pyocyanin (Mavrodi et al. 2001). Our finding suggested that 
one probable reason for the reduced pyocyanin phenotype was insufficient expression of 
phzM gene. However, at this point, we do not know whether PA4326 affects the phzM 
expression directly or indirectly. We examined the possible effects of PA4326 on quorum 
sensing signaling molecule C4-HSL, because C4-HSL and its receptor RhlR have a 
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positive regulatory effects in the expression of phzA1 gene locus (Whiteley et al. 1999). 
However, we did not observe any statistically significant variation in C4-HSL level 
among strains (Fig. 11), which implied that the level of C4-HSL was not involved in 
pyocyanin deficiency in ∆PA4326 strains. Moreover, we also showed qualitatively (Fig. 
12) that in ∆PA4326 strains, PQS (2-alkal-4-quinolone) signaling, which promotes the 
expression of rhlI and rhlR required for C4-HSL synthesis (McKnight et al. 2000), was 
likewise unaffected. 
In a recent paper, it has been reported that phenazines control colony size and 
biofilm thickness in P. aeruginosa strain PA14 (Ramos et al. 2010). Phenazines have also 
been implicated to control gene expression and community behavior, as well as thickness 
of Pseudomonas chlororaphis biofilms (Dietrich et al. 2008; Maddula et al. 2008; Ramos 
et al. 2010).  Moreover, Das et al. have found that pyocyanin promotes extracellular 
DNA release, which is required to maintain biofilm integrity in P aeruginosa (Das & 
Manefield 2012). However, in our biofilm assay in PVC with our pyocyanin defective 
∆PA4326 strains, we did not find any significant variations in biofilm levels among 
different strains at various time points (Fig. 13). This discrepancy in observations 
between biofilm systems may be due to the differences in experimental approaches used 
in previous studies. Similar to Ramos et al., we observed that pyocyanin might not 
influence the surface attachment (early biofilm) of the PA14 strain, which data contrast 
with observations with P. chlororaphis (Ramos et al. 2010; Maddula et al. 2008). 
However, Ramos et al. also reported that pyocyanin might influence the swarming 
motility, whereas we failed to find similar effects (Fig. 14) with our ∆PA4326 strain 
(Ramos et al. 2010). This previous study  used a double phz1/2 mutant, which was 
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completely deficient in any phenazine production (Dietrich et al. 2006).  Further studies 
using co-culture CFBE biofilm assay will give a more clinically-significant picture of the 
relationship, if any, between PA4326, pyocyanin, and biofilm formation (Anderson et al. 
2008). 
In this study, we presented the role of a previously unstudied putative lipoprotein 
PA4326 in P. aeruginosa-mediated cytotoxicity towards airway cells. In the future, in-
depth analysis on how CFBE cells respond to with bacterial lipoproteins, like PA4326, 
will facilitate better understanding of this dynamic host/virulence interplay. Nonetheless, 
our current research has shown the importance of PA4326 in bacterial virulence and may 
lead toward novel anti-inflammatory therapies against lipoproteins like PA4326 which 
would lessen the suffering of the patients with CF. 
.
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Table 1: Experimental Organisms 
Organisms Description or Purpose Source 
Pseudomonas aeruginosa 
PA14 
wild type, clinical isolate Rahme et al.1995 
Pseudomonas aeruginosa 
GGA50 
PA14 ∆PA4326 This study 
Staphylococcus aureus  
MZ100 
Wild type 
Shanks et al., 2005 
Agrobacterium tumefaciens 
NTL4 
With two plasmids: tra gene 
and traI-traZ fusion  
Fuqua & Winans, 1996; 
Fuqua et al., 1996; Stickler 
et al., 1998 
Pseudomonas aeruginosa 
PA0-JP2/pECP62.5 
PA01 lasI
-
/rhlI
-
 with 
pECP61.5 plasmid 
Pearson et al.,1997 
S. cerevisiae InvSc1 
ura3-52 / ura3-52; creation 
of plasmids by homologous 
recombination 
Invitrogen 
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Table 2: Description of plasmids  
Plasmid Description Source 
pSSA004 
Complementation of PA4326 
gene 
This study 
pMQ72 
Control expression vector 
with gentamicin-resistant 
gene 
Shanks et al. 
pMQ30 Suicide vector Shanks et al. 
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Table 3: Description of primers: 
Primer Sequence (5’ – 3’) 
4326L For aattctgttttatcagaccgcttctgcgttctgatttaatcaccatcgactacctgaatg 
4326L Rev gatacagttcccaacggaggggatttcacggaggaggttc 
4326R For gaacctcctccgtgaaatcccctccgttgggaactgtatc 
4326R Rev ggaattgtgagcggataacaatttcacacaggaaacagcaccagcaggttatgcaggttc 
4326F cgcgacgagcatcgaaatac 
4326R cccttcagtcacgccaatac 
4326Comfor tactgtttctccatacccgtttttttgggctagcgaattcaggaggagcgcgctatgcctatgcgaagcttg
atc 
4326Comrev ctgtatcaggctgaaaatcttctctcatccgccaaaacagctacaggcgggacggcacgg 
5110forA ttcgccatcaacatgtccaaccag 
5110revA acatcgggttggcttcgtacatcag 
phzMRTFor aaggcaagtcgctggtgaactg 
phzMRTRev tactgcaggatcaactggttgcg 
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Figure 1: Type II (lipoprotein) export signal predicted by LipoP (cleavage after residue 
17). SpI = signal peptide (signal peptidase I) SpII = lipoprotein signal peptide (signal 
peptidase II) CYT = cytoplasmic. 
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Figure 2: Cell monolayers are killed by P. aeruginosa Wild Type (WT) but not killed by 
the ∆PA4326 mutant, 8 hours after incubation, cultured on CF-derived bronchial 
epithelial cells (CFBE cells). 
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Figure 3: The ∆PA4326 mutant strain is less toxic to CFBE cells than the wild type 
(WT), measured by Lactate Dehydrogenase (LDH) release after 6 hours. 
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Figure 4:  Cytotoxicity Assay shows that the ΔPA4326 strain is less cytotoxic. 
∆PA4326 with complementation plasmid was significantly more cytotoxic than ∆PA4326 
with empty vector. The Y-axis displays percent cytotoxicity, normalized as a percentage 
of maximum LDH release from CFBE cells treated with Triton
®
 X-100. PA14 is the wild 
type strain, p4326 is the PA4326 complementation plasmid, and pMQ72 is the empty 
vector. Data are representative of 4 independent experiments, performed in triplicate. *p< 
0.05.  
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Figure 5: Growth is unaffected by mutation of PA4326.  Absorbance values were 
measured at 600 nm in a spectrophotometer held at 37°C. Here, both the wild type and 
∆PA4326 strains showed similar growth patterns. Data are representative of 3 
independent experiments performed in triplicate. 
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Figure 6:  Mutation of PA4326 reduces apoptosis and necrosis in CFBE cells 
cultured with bacteria. Three and a half hours post-inoculation with wild type PA14 and 
∆PA3226, CFBE cells were triple stained with PE-conjugated anti-human antibody D34 
monoclonal antibody, annexin V-FITC, and 7 aminoactinomycinD (7AAD). According to 
the control samples (Not shown in figure), the lower right quadrant was defined as early 
apoptotic cells, which bindannexin V but still retain their cytoplasmic integrity and 
exclude 7AAD, whereas the upper right quadrant represents nonviable, late 
apoptotic/necrotic cells, which are positive for annexin V and actinomycin D staining. 
Left Panel: 38.75% of the cells inoculated with PA14 wild type were late 
apoptotic/necrosis cells. Right panel: 29.26% of the stimulated with ∆PA4326 were late 
apoptotic/necrosis. Data represent a single experiment. 
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Figure 7: Decreased IL-8 secretion from CFBE cells inoculated with the PA4326 
mutant. IL-8 levels in the supernatant of CFBE monolayers inoculated with wild type 
∆PA4326 strains were measured by ELISA (detection Limit 12.5 to 800 pg/ml). p4326 is 
the complementation plasmid and pMQ72 is the empty vector. The results are the means 
of four independent experiments ± the standard deviation. *p<0.05. 
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Figure 8: ∆PA4326 culture is less green than wild type. The bacterial cultures were 
grown overnight at 37⁰ C in LB media. Qualitative observations reveal a lighter color to 
ΔPA4326 cultures than wild type. p4326 is the complementation plasmid.  
 
 
 
 
 
 
50 
 
 
Figure 9: ∆PA4326 affects pyocyanin levels. The pyocyanin levels of the bacterial 
strains were determined by spectrophotometry of chloroform extracted bacterial fraction 
(Essar et al. 1990), as described in Materials and Methods. We found less pyocyanin in 
A) culture supernatants and B) whole cell lysates of ΔPA4326 than in these fractions of 
wild type. Results are representative of three independent experiment performed in 
triplicate. *p<0.05.  
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Figure 10: Deletion of PA4326 results in reduced expression of phzM. Transcript level 
was assessed by qPCR. Data were normalized to control transcript PA5110.  The 
presented results are the mean value of four independent experiments performed in 
triplicate. *p <0.05. 
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Figure 11: Level of C
4
-HSL molecules within the supernatant fraction of the strains 
(PA14 WT and ΔPA4326). As described in methods, the level was quantified as Miller 
Units of β–galactosidase activity in the cross-feeding activity. No statistically significant 
differences were observed among the strains. Data are representative of 3 independent 
experiments. 
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Figure 12: Deletion of PA4326 does not disrupt PQS levels. The plates were swabbed 
with S. aureus and spotted with four different constructs (∆PA4326/p4326, 
∆PA14/pMQ72, ∆PA14/p4326, and ∆PA4326/pMQ72). After incubation overnight at 37⁰ 
C, the zones of inhibition were observed for these different strains.  Data are 
representative of 3 independent experiments. 
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Figure 13: ∆PA4326 forms comparable biofilm to wild type at various time points. 
As described in the methods, wild type and ∆PA4326 were assayed for biofilm formation 
in minimal M63 media supplemented with 0.4% arginine. No statistically significant 
differences were observed among the strains. 
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Figure 14: Motility of ∆PA4326. A) Swarming motility was identical between wild type 
and ΔPA4326 strains. Shown are 5 replicate assays, depicting wild type on the left side of 
the plate and ΔPA4326 on the right side. B) Swimming motility was significantly 
decreased in the ΔPA4326 strain, compared to wild type. The swimming zones were 
measured after 16 to 20 hours of incubation at 37⁰ C. *p< 0.05.  
 
